Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Suven Life Sciences...

    Suven Life Sciences provide financial assistance of Rs 70 lakh to Bharosa

    GarimaWritten by Garima Published On 2019-03-17T10:21:21+05:30  |  Updated On 17 March 2019 10:21 AM IST
    Suven Life Sciences provide financial assistance of Rs 70 lakh to Bharosa

    Suven Life Sciences has also agreed to provide contribute yearly maintenance cost of Rs 30 lakh over the next five years for the centre.


    Hyderabad: As part of their Corporate Social Responsibility(CSR), Suven Life Sciences has donated an amount of Rs 70 lakh to 'Bharosa', a support centre for women and children, to enable it to construct SHE-Bharosa centre in Suryapet district. According to recent media reports, it has also agreed to provide contribute yearly maintenance cost of Rs 30 lakh over the next five years for the centre.


    Bharosa, the Hyderabad police’s support centre for women and children, signed a Memorandum of Agreement (MoA) with Suven Life Sciences.


    Also Read: Suven Life Sciences secures Product Patents in Australia and Singapore


    The memorandum of agreement (MoA) was signed in the presence of Director-General of Police, M Mahendar Reddy, Suven Trust Managing Trustee Venkat Jasti, Additional Director-General of Police Jitender, Inspector General of Police (Law & Order) and In-Charge (Women Safety) Swati Lakra and other officials.





    The MoA’s objective was to financially support SHE-Bharosa centre by funding it for next five years and to strengthen and popularize women and child protection initiatives. Another objective was to sensitize women and children about safety and security as well as support services available during crisis, reports Telangana Today.


    SHE Teams was introduced in the state in 2014 with a motto to provide safety and security to women and to curb crimes against women. Bharosa is an integrated support centre for women and children that was established by the city police in 2016. The centre helps resolve conflicts in families and provides services related to police, medical, legal and psycho-therapeutic counselling.


    Suven Life Sciences Ltd. (Suven) is an Indian life sciences company based in Hyderabad, Telangana, India. Established in 1989 as a private limited company, it went public in 1995. The company designs, manufactures and supplies bulk actives, drug intermediates and fine chemicals to domestic and international players in the bio-pharmaceuticals industry.



    Also Read: Suven Life Sciences enters asset purchase agreement with Rising Pharma






    bharosadirector general of policeHyderabadhyderabad newsm mahendar reddymemorandum of agreement (moa)newSuvenSuven Life SciencesSuven Trustsuven trust managing trustee venkat jastiSuven TrusteeTelanganatelangana news
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok